Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.47B$2.47Bderived+4.5% vs Q4 2020 Net Income$41.98M$41.98Mderived−17.3% vs Q4 2020 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$341,571,000−14.3% Operating Incomederived$62,022,000−35.1% Operating Cash Flowderived$50,341,000−29.1% Free Cash Flowderived$35,802,000−15.3% Margins · derivedGross margin13.8%−3.0 pt vs Q4 2020
Operating margin2.5%−1.5 pt vs Q4 2020
Net margin1.7%−0.4 pt vs Q4 2020
ended Dec 31, 2021 · filed Feb 23, 2022 · 54 d after period end